Skip to main content

Table 5 Appraisal of Guidelines for Research and Evaluation (AGREE) II reporting grid summary from four independent assessors

From: Canadian 24-Hour Movement Guidelines for the Early Years (0–4 years): An Integration of Physical Activity, Sedentary Behaviour, and Sleep

AGREE II Item Reporting Location Domain Score (%)b
Domain 1. Scope and Purpose 100
1. The overall objective(s) of the guideline is (are) specifically described. • Guideline Development Report
• This manuscript
2. The health question(s) covered by the guideline is (are) specifically described. • Guideline Development Report
• This manuscript
• Systematic reviews [18, 21,22,23] and PROSPERO Registrations
3. The population (patients, public, etc.) to whom the guideline is meant to apply is specifically described. • Guideline Development Report
• This manuscript
Domain 2. Stakeholder Involvement 99
4. The guideline development group includes individuals from all the relevant professional groups. • Guideline Development Report
• This manuscript
5. The views and preferences of the target population (patients, public, etc.) have been sought. • Guideline Development Report
• This manuscript
• Focus groups and key informant interviews [33]
6. The target users of the guideline are clearly defined. • Guideline Development Report
• This manuscript
Domain 3. Rigour of Development 95
7. Systematic methods were used to search for evidence. • Guideline Development Report
• Systematic reviews [18, 21,22,23, 60]
8. The criteria for selecting the evidence are clearly described. • Guideline Development Report
• Systematic reviews [18, 21,22,23, 60]
9. The strengths and limitations of the body of evidence are clearly described. • Guideline Development Report
• This manuscript
• Systematic reviews [18, 21,22,23, 60]
10. The methods for formulating the recommendations are clearly described. • Guideline Development Report
• This manuscript
11. The health benefits, side effects, and risks have been considered in formulating the recommendations. • Guideline Development Report
• This manuscript
• Systematic reviews [18, 21,22,23, 47, 49, 60]
12. There is an explicit link between the recommendations and the supporting evidence. • Guideline Development Report
13. The guideline has been externally reviewed by experts prior to its publication. • Guideline Development Report
• This manuscript
• Focus groups and key informant interviews [33]
14. A procedure for updating the guideline is provided. • Guideline Development Report
• This manuscript
Domain 4. Clarity of Presentation 99
15. The recommendations are specific and unambiguous. • Guideline Development Report
• This manuscript
16. The different options for management of the condition or health issue are clearly presented.a • Not applicable
17. Key recommendations are easily identifiable. • Guideline Development Report
• This manuscript
Domain 5. Applicability 89
18. The guideline describes facilitators and barriers to its application. • Guideline Development Report
• This manuscript
• Focus groups and key informant interviews [33]
19. The guideline provides advice and/or tools on how the recommendations can be put into practice. • Guideline Development Report
• This manuscript
• CSEP website (www.csep.ca/guidelines)
20. The potential resource implications of applying the recommendations have been considered. • Guideline Development Report
• This manuscript
21. The guideline presents monitoring and/or auditing criteria. • Guideline Development Report
• This manuscript
Domain 6. Editorial Independence 89
22. The views of the funding body have not influenced the content of the guideline. • Guideline Development Report
• This manuscript
23. Competing interests of guideline development group members have been recorded and addressed. • This manuscript
• Systematic reviews [18, 21,22,23]
  1. aItem 16 was rated as “not applicable” by one reviewer and assessments from the other reviewers were included in the scaled Domain 4 score
  2. bFour independent reviewers applied the AGREE II assessment; the Domain Scores (%) were calculated by summing all the scores of the individual items in a domain and by scaling the total as a percentage of the maximum possible score for that domain (as per the AGREE II Instrument, available at www.agreetrust.org). The “Reporting Location” is not a comprehensive summary of all places where the information in each item can be found. The Guideline Development Report is available at www.csep.ca/guidelines